Skip to main content

Advertisement

Log in

Synthesis and anti-inflammatory effects of a series of novel 9-O-substituted berberine derivatives

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Berberine owns multiple pharmacological activities, especially anti-inflammatory activity. To enhance the anti-inflammatory therapeutic efficiency of berberine, a series of novel 9-O-substituted berberine derivatives (5a5d) were synthesized and their anti-inflammatory activities were evaluated. 13C-NMR, 1H-NMR, IR and high resolution mass spectrum (HRMS) results indicated that these derivatives were successfully synthesized. The xylene-induced inflammatory mice model demonstrated that these derivatives showed dose-dependent inhibition of ear inflammatory swelling. Comparing to berberine, ibuprofen and naproxen-modified berberine derivatives enhanced anti-inflammatory activities, while aspirin and nicotinic acid-modified berberine derivatives showed lower anti-inflammatory effects at the same dosages. This could be attributed to the enhanced inhibition of secretion of cytokines, including interleukin-6 and tumor necrosis factor-α, by ibuprofen and naproxen berberine derivatives, while aspirin and nicotinic acid berberine derivatives showed lower inhibition of tumor necrosis factor-α than berberine. These results suggest that ibuprofen and naproxen-modified berberine derivatives are promising new anti-inflammatory drug candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Scheme 1

Similar content being viewed by others

References

  • Ahmed T, Gilani AU, Abdollahi M, Daglia M, Nabavi SF, Nabavi SM (2015) Berberine and neurodegeneration: a review of literature. Pharmacol Rep 67:970–979

    Article  CAS  PubMed  Google Scholar 

  • Anis KV, Rajeshkumar NV, Kuttan R (2001) Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 53:763–768

    Article  CAS  PubMed  Google Scholar 

  • Bodiwala HS, Sabde S, Mitra D, Bhutani KK, Singh IP (2011) Synthesis of 9-substituted derivatives of berberine as anti-HIV agents. Eur J Med Chem 46:1045–1049

    Article  CAS  PubMed  Google Scholar 

  • Borges RS, Castle SL (2015) The antioxidant properties of salicylate derivatives: a possible new mechanism of anti-inflammatory activity. Bioorg Med Chem Lett 25:4808–4811

    Article  CAS  PubMed  Google Scholar 

  • Bremner JB, Ambrus JI, Samosorn S (2007) Dual action-based approaches to antibacterial agents. Curr Med Chem 14:1459–1477

    Article  CAS  PubMed  Google Scholar 

  • Cai Y, Xia Q, Luo R, Huang P, Sun Y, Shi Y, Jiang W (2014) Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med 68:53–62

    Article  CAS  PubMed  Google Scholar 

  • Caliceti C, Franco P, Spinozzi S, Roda A, Cicero AF (2016) Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Curr Med Chem 23:1460–1476

    Article  CAS  PubMed  Google Scholar 

  • Cao Y, Bei W, Hu Y, Cao L, Huang L, Wang L, Luo D, Chen Y, Yao X, He W (2012) Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats. Phytomedicine 19:686–692

    Article  CAS  PubMed  Google Scholar 

  • Cardinal S, Azelmat J, Grenier D, Voyer N (2016) Anti-inflammatory properties of quebecol and its derivatives. Bioorg Med Chem Lett 26:440–444

    Article  CAS  PubMed  Google Scholar 

  • Choi BH, Ahn IS, Kim YH, Park JW, Lee SY, Hyun CK, Do MS (2006) Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 38:599–605

    Article  CAS  PubMed  Google Scholar 

  • German N, Wei P, Kaatz GW, Kerns RJ (2008) Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. Eur J Med Chem 43:2453–2463

    Article  CAS  PubMed  Google Scholar 

  • Gratas DA, Derbré F, Vincent S, Cillard J (2014) Physical inactivity, insulin resistance, and the oxidative-inflammatory loop. Free Radic Res 48:93–108

    Article  Google Scholar 

  • Gu L, Li N, Gong J, Li Q, Zhu W, Li J (2011) Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis 203:1602–1612

    Article  CAS  PubMed  Google Scholar 

  • Hsu YY, Tseng YT, Lo YC (2013) Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. Toxicol Appl Pharmacol 272:787–796

    Article  CAS  PubMed  Google Scholar 

  • Hu Y, Chen X, Duan H, Hu Y, Mu X (2009) Chinese herbal medicinal ingredients inhibit secretion of IL-6, IL-8, E-selectin and TXB2 in LPS-induced rat intestinal microvascular endothelial cells. Immunopharmacol Immunotoxicol 31:550–555

    Article  CAS  PubMed  Google Scholar 

  • Kim S, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE (2008) Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13:2975–2985

    Article  CAS  PubMed  Google Scholar 

  • Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 24:317–324

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Ekavali, Chopra K, Mukherjee M, Pottabathini R, Dhull DK (2015) Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol 761:288–297

    Article  CAS  PubMed  Google Scholar 

  • Kuo CL, Chi CW, Liu TY (2004) The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127–137

    Article  CAS  PubMed  Google Scholar 

  • Lal K, Yadav P, Kumar A (2016) Synthesis, characterization and antimicrobial activity of 4-((1-benzyl/phenyl-1H-1,2,3-triazol-4-yl)methoxy)benzaldehyde analogues. Med Chem Res 25:644–652

    Article  CAS  Google Scholar 

  • Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G (2015) Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol 161:69–81

    Article  CAS  PubMed  Google Scholar 

  • Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY (2007) Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells. Pharmacol Res 56:193–201

    Article  CAS  PubMed  Google Scholar 

  • Lee GE, Lee HS, Lee SD, Kim JH, Kim WK, Kim YC (2009) Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists. Bioorg Med Chem Lett 19:954–958

    Article  CAS  PubMed  Google Scholar 

  • Li N, Gu L, Qu L, Gong J, Li Q, Zhu W, Li J (2010) Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells. Eur J Pharm Sci 40:1–8

    Article  PubMed  Google Scholar 

  • Lin WC, Lin JY (2011) Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro. J Agric Food Chem 59:184–192

    Article  CAS  PubMed  Google Scholar 

  • Liu SC, Lee HP, Hung CY, Tsai CH, Li TM, Tang CH (2015) Berberine attenuates CCN2-induced IL-1beta expression and prevents cartilage degradation in a rat model of osteoarthritis. Toxicol Appl Pharmacol 289:20–29

    Article  CAS  PubMed  Google Scholar 

  • Lou T, Zhang Z, Xi Z, Liu K, Li L, Liu B, Huang F (2011) Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation 34:659–667

    Article  CAS  PubMed  Google Scholar 

  • Mohammad M, Al-masri IM, Issa A, Khdair A, Bustanji Y (2012) Inhibition of pancreatic lipase by berberine and dihydroberberine: an investigation by docking simulation and experimental validation. Med Chem Res 22:2273–2278

    Article  Google Scholar 

  • Ni WJ, Ding HH, Tang LQ (2015) Berberine as a promising anti-diabetic nephropathy drug: an analysis of its effects and mechanisms. Eur J Pharmacol 760:103–112

    Article  CAS  PubMed  Google Scholar 

  • Nishihata T, Rytting JH, Higuchi T (1982) Enhanced rectal absorption of theophylline, lidocaine, cefmetazole, and levodopa by several adjuvants. J Pharm Sci 71:865–869

    Article  CAS  PubMed  Google Scholar 

  • Olusi SO, Al-Awadhi A, Abraham M (2003) Relations of serum interleukin 18 levels to serum lipid and glucose concentrations in an apparently healthy adult population. Horm Res 60:29–33

    CAS  PubMed  Google Scholar 

  • Samosorn S, Tanwirat B, Muhamad N, Casadei G, Tomkiewicz D, Lewis K, Suksamrarn A, Prammananan T, Gornall KC, Beck JL, Bremner JB (2009) Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg Med Chem 17:3866–3872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shan WJ, Huang L, Zhou Q, Meng FC, Li XS (2011) Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-beta aggregation. Eur J Med Chem 46:5885–5893

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Gupta S, Khajuria V, Bhagat A, Ahmed Z, Shah BA (2016) Analogues of boswellic acids as inhibitors of pro-inflammatory cytokines TNF-alpha and IL-6. Bioorg Med Chem Lett 26:695–698

    Article  CAS  PubMed  Google Scholar 

  • Sun Y, Xun K, Wang Y, Chen X (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20:757–769

    Article  CAS  PubMed  Google Scholar 

  • Tamura T, Masaki S, Ohmori K, Karasawa A (2005) Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice. Pharmacology 75:45–52

    Article  CAS  PubMed  Google Scholar 

  • Wang F, Sun JR, Huang MY, Wang HY, Sun PH, Lin J, Chen WM (2014) Design, synthesis and anti-inflammatory evaluation of novel 5-benzylidene-3,4-dihalo-furan-2-one derivatives. Eur J Med Chem 72:35–45

    Article  CAS  PubMed  Google Scholar 

  • Wu M, Wang J, Liu Lt (2010) Advance of studies on anti-atherosclerosis mechanism of berberine. Chin J Integr Med 16:188

    Article  CAS  PubMed  Google Scholar 

  • Wu X, Li Y, Wang Q, Li W, Feng Y (2015) Effects of berberine and pomegranate seed oil on plasma phospholipid metabolites associated with risks of type 2 diabetes mellitus by U-HPLC/Q-TOF-MS. J Chromatogr B 1007:110–120

    Article  CAS  Google Scholar 

  • Xie X, Chang X, Chen L, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H (2013) Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Mol Cell Endocrinol 381:56–65

    Article  CAS  PubMed  Google Scholar 

  • Yang J, Wang HD, Lu DX, Wang YP, Qi RB, Li J, Li F, Li CJ (2006) Effects of neutral sulfate berberine on LPS-induced cardiomyocyte TNF-alpha secretion, abnormal calcium cycling, and cardiac dysfunction in rats. Acta Pharmacol Sin 27:173–178

    Article  CAS  PubMed  Google Scholar 

  • Zhang SS, Wang XH, Yin WC, Liu ZB, Zhou M, Xiao DP, Liu YF, Peng DM (2016) Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives. Bioorg Med Chem Lett 26:4799–4803

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded by National Natural Science Foundation of China (81301258), Hunan Provincial Natural Science Foundation of China (2016JJ2161), Specialized Research Fund for the Doctoral Program of Higher Education of China (20130162120078), China Postdoctoral Science Foundation (2013M540644), International Postdoctoral Exchange Fellowship Program (2014) 29 (20140014) and Shenghua Yuying Project of Central South University. The authors acknowledge the NMR measurements by The Modern Analysis and Testing Center of Central South University.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yanfei Liu or Dongming Peng.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Z., Wang, X., Zhang, H. et al. Synthesis and anti-inflammatory effects of a series of novel 9-O-substituted berberine derivatives. Med Chem Res 26, 672–679 (2017). https://doi.org/10.1007/s00044-017-1787-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-017-1787-z

Keywords

Navigation